VTCN1 and neoplasm: Given what is now known about B7-H1 (PD-L1, programmed cell death 1 ligand 1) [17], examining B7H4 expression patterns and distribution in tumor microenvironment may provide additional insights into how B7H4 works in human cancer and immune response.